Mark Haden

Corporate Officer/Principal bei CLEARMIND MEDICINE INC.

Vermögen: 150 $ am 31.05.2024

70 Jahre

Health Technology

Consumer Services

Aktive Positionen von Mark Haden

Unternehmen	Position	Beginn	Ende
CLEARMIND MEDICINE INC.	Corporate Officer/Principal	01.07.2021	-

Unternehmen	Position	Beginn	Ende
Psygen Labs, Inc. Psygen Labs, Inc. Pharmaceuticals: GenericHealth Technology Psygen Labs, Inc. is a psychedelics manufacturer that provides non-exclusive access to psychedelic drug products for clinical research and therapeutic applications. The company is based in Calgary, Canada. With over 50 years of combined experience synthesizing psychedelics, the Canadian company is well positioned to be a lead supplier for the emerging commercial market. The CEO of the company is Danny Motyka.	Corporate Officer/Principal	01.04.2021	01.03.2022

University of British Columbia

Graduate Degree

International

Kanada

Operativ

Corporate Officer/Principal	2
Graduate Degree	1
Undergraduate Degree	1

Sektoral

Health Technology	3
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
CLEARMIND MEDICINE INC.	Health Technology

Private Unternehmen	1
Psygen Labs, Inc. Psygen Labs, Inc. Pharmaceuticals: GenericHealth Technology Psygen Labs, Inc. is a psychedelics manufacturer that provides non-exclusive access to psychedelic drug products for clinical research and therapeutic applications. The company is based in Calgary, Canada. With over 50 years of combined experience synthesizing psychedelics, the Canadian company is well positioned to be a lead supplier for the emerging commercial market. The CEO of the company is Danny Motyka.	Health Technology

Private Unternehmen

Health Technology